The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of VAL-083 in GBM AGILE, a phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma.
 
John Frederick de Groot
Employment - Alaunos Therapeutics (I); Brii Biosciences (I)
Stock and Other Ownership Interests - Alaunos Therapeutics (I); Brii Biosciences (I); WuXi Biologics
Consulting or Advisory Role - Alpha Pharmaceutical; Aucentra Therapeutics; Bioasis Technologies; CarThera; Chimerix; Cure Brain Cancer Foundation; InSightec; Karyopharm Therapeutics; Kazia Therapeutics; Kintara Therapeutics; Merck; Midatech Pharma; Monteris Medical; Mundipharma Research; Samus Therapeutics; Sapience Therapeutics; SERVIER; Sumitomo Dainippon Pharma Oncology; Telix Pharmaceuticals; VBI Vaccines
Research Funding - CarThera (Inst); Haihe Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
Other Relationship - Chimerix; VBI Vaccines
 
Timothy Francis Cloughesy
Leadership - Katmai Pharmaceuticals
Stock and Other Ownership Interests - Chimerix; Erasca, Inc; Katmai Pharmaceuticals
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Chimerix; DelMar Pharmaceuticals; Global Coalition for Adaptive Research; Inovio Pharmaceuticals; Katmai Pharmaceuticals; KIYATEC; Lista; Merck; Mundipharma; Novartis; QED Therapeutics; Roche/Genentech; Sapience Therapeutics; SERVIER; SonaCare Medical; SymBio Pharmaceuticals; Tango Therapeutics; Tocagen; VBL Therapeutics
Patents, Royalties, Other Intellectual Property - U.S. Provisional Application No.: 62/819,322 Title: COMPOSITIONS AND METHODS FOR TREATING CANCER Filing Date: March 15, 2019 Inventor(s): David A. Nathanson et al. FH Reference No.: UCH-17760 (32246-17760) Your Reference No.: [UCLA 2019-630-1] US
Other Relationship - Break Through Cancer; Global Coalition for Adaptive Research
 
Donald A. Berry
Employment - Berry Consultants
Leadership - Berry Consultants
Stock and Other Ownership Interests - Berry Consultants
Consulting or Advisory Role - Berry Consultants
Travel, Accommodations, Expenses - Berry Consultants
 
Meredith Becker Buxton
No Relationships to Disclose
 
Howard Colman
Consulting or Advisory Role - Adastra Pharmaceuticals; Best Doctors, Inc; Bristol-Myers Squibb; Novocure; Orbus Therapeutics; PPD/Chimerix; Regeneron
Research Funding - Abbvie (Inst); Array BioPharma (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); DNAtrix (Inst); Erasca, Inc (Inst); FORMA Therapeutics (Inst); Global Coalition for Adaptive Research (Inst); Kadmon (Inst); Merck (Inst); Nuvation Bio (Inst); Orbus Therapeutics (Inst); Samus Therapeutics (Inst); Sumitomo Dainippon Pharma Oncology (Inst)
Travel, Accommodations, Expenses - Bayer; FORMA Therapeutics; Karyopharm Therapeutics; Orbus Therapeutics; Regeneron
 
Benjamin M. Ellingson
Consulting or Advisory Role - Alpheus Medical; CarThera; Chimerix; Curtana; Ellipses Pharma; Global Coalition for Adaptive Research; Imaging Endpoints; ImmunoGenesis; Medicenna; Monteris Medical; Neosoma; Orbus Therapeutics; Sagimet Biosciences; Sapience Therapeutics; SERVIER; Siemens; Sumitomo Dainippon Pharma Oncology; Voiant/MedQIA
Research Funding - Siemens
Travel, Accommodations, Expenses - Siemens
 
Gary B. Gordon
Employment - Abbott Laboratories; Abbvie; Ayala Pharmaceuticals; Global Coalition for Adaptive Research
Leadership - Biosight; PhotonPharma
Stock and Other Ownership Interests - Abbott Laboratories; AbbVie; Ayala Pharmaceuticals
Consulting or Advisory Role - Molecular Templates
Travel, Accommodations, Expenses - Ayala Pharmaceuticals; Global Coalition for Adaptive Research; Global Coalition for Adaptive Research
 
Andrew B. Lassman
Honoraria - Clinical Education Alliance
Consulting or Advisory Role - Affinia Therapeutics; BioClinica; Global Coalition for Adaptive Research; Leal Therapeutics; Orbus Therapeutics; RadMD as an expert blinded independent reviewer of clinical and imaging data for a Roche-sponsored trial; Sapience Therapeutics; Servier
Research Funding - Abbott Laboratories (Inst); Abbvie (Inst); Aeterna Zentaris (Inst); Bayer (Inst); Biohaven Pharmaceuticals (Inst); BMS (Inst); Chimerix (Inst); Corden (Inst); DelMar Pharmaceuticals (Inst); Genentech/Roche (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Kazia Therapeutics (Inst); Kintara Therapeutics (Inst); NextSource (Inst); Novartis (Inst); Orbus Therapeutics (Inst); Pfizer (Inst); Polaris (Inst); QED Therapeutics (Inst); Servier (Inst); VBI Vaccines (Inst); Vigeo Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; Anheart Therapeutics; Bridgebio; Chimerix; Foundation Medicine; Gilead Sciences; Global Coalition for Adaptive Research; Helsinn Healthcare; Servier; VBI Vaccines
 
Michael Lim
Stock and Other Ownership Interests - Egret Bioscience
Consulting or Advisory Role - Biohaven Pharmaceuticals; Century Therapeutics; CRAniUS; Hemispherian; InCando; InCephalo Therapeutics/University of Zurich; InSightec; Mediflix; Merck; Novocure; Noxxon Pharma; Pyramid Biosciences; Sanionoia; VBI Vaccines; XSense
Research Funding - Accuray; Arbor Pharmaceuticals; Biohaven Pharmaceuticals; Bristol-Myers Squibb; UroGen pharma
Patents, Royalties, Other Intellectual Property - Checkpoints for Neuro-Inflammation; Focused radiation and checkpoint inhibitors; Local chemotherapy + checkpoint inhibitors
Other Relationship - Stryker
 
Ingo K. Mellinghoff
Honoraria - Black Diamond Therapeutics; Hartford HealthCare; Prelude Therapeutics; Roche
Consulting or Advisory Role - Agios; Black Diamond Therapeutics; Cardinal Health; Debiopharm Group; Divide and Conquer; Global Coalition for Adaptive Research; Novartis; Roche; SERVIER; Voyager Therapeutics
Research Funding - Amgen; General Electric; Kazia Therapeutics; Lilly; SERVIER
Travel, Accommodations, Expenses - Agios; AstraZeneca; Puma Biotechnology; Roche; Voyager Therapeutics
 
Erik P. Sulman
Honoraria - Baptist Health South Florida; BrainLAB; Peerview
Consulting or Advisory Role - Global Coalition for Adaptive Research; Harvard Medical School; Telix Pharmaceuticals
Research Funding - Novocure (Inst)
Patents, Royalties, Other Intellectual Property - CARPOOL pooled cell line drug screening
Travel, Accommodations, Expenses - Baptist Health South Florida; BrainLAB; Peerview
 
Michael Weller
Honoraria - Bayer; Novocure; Pierre Fabre (I)
Consulting or Advisory Role - Bayer (I); Curevac; Janssen (I); LEO Pharma (I); Medac; Novartis; Orbus Therapeutics; Philogen; Roche; Sandoz; Seagen (I)
Research Funding - Quercegen Pharmaceuticals (Inst); Versameb (Inst)
 
Patrick Y. Wen
Consulting or Advisory Role - Anheart Therapeutics; AstraZeneca; Bayer; Black Diamond Therapeutics; Boehringer Ingelheim; Celularity; Chimerix; Day One Biopharmaceuticals; Genenta Science; GlaxoSmithKline; Insightec; Kintara Therapeutics; Merck; Mundipharma; Mundipharma; Novartis; Novocure; Novocure; Prelude Therapeutics; Prelude Therapeutics; Sagimet Biosciences; Sapience Therapeutics; Servier; Servier; SymBio Pharmaceuticals; Tango Therapeutics; Telix Pharmaceuticals; VBI Vaccines
Research Funding - AstraZeneca (Inst); Bayer (Inst); Black Damond (Inst); Chimerix (Inst); Erasca, Inc (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); MediciNova (Inst); Merck (Inst); Novartis (Inst); Nuvation Bio (Inst); Quadriga Biosciences (Inst); Servier (Inst); Vascular Biogenics (Inst); VBI Vaccines (Inst)
 
Emma Maria Viktoria Hyddmark
Research Funding - Bayer (Inst); Biohaven Pharmaceuticals (Inst); Kazia Therapeutics (Inst); Kintara Therapeutics (Inst); Polaris (Inst); Vigeo Therapeutics (Inst)
 
Tom Mikkelsen
No Relationships to Disclose
 
Scott Peter Owen
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck; Novocure; Roche Canada; Takeda
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Merck; Roche Canada; Takeda
 
Warren P. Mason
Honoraria - Apotex; Bayer; GlaxoSmithKline; Viatris
Consulting or Advisory Role - Novocure; Ono Pharmaceutical
Expert Testimony - Medcan
 
Jan Drappatz
Leadership - Elsevier
Stock and Other Ownership Interests - Biogen; Bristol-Myers Squibb; Exelixis; Gilead Sciences; GlaxoSmithKline; Pfizer
Honoraria - Elsevier; UpToDate
Consulting or Advisory Role - Agios; Immunomic Therapeutics; Novocure; Oncorus
Patents, Royalties, Other Intellectual Property - uptodate
 
Nicholas Alfred Blondin
No Relationships to Disclose
 
James R. Perry
Leadership - Global Coalition for Adaptive Research
Stock and Other Ownership Interests - Synaptive medical
Honoraria - Novocure; SERVIER
Consulting or Advisory Role - Servier Canada